5 Nov 2020 07:00
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (LSE: MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, has received notification from Dr Stuart Quin, Chief Executive Officer of Medica, that on 4 November 2020 he purchased a total of 27,680 ordinary shares of 0.2p in the Company ("Shares") at a price of 107.3p per Share.
Following this transaction, Stuart Quin has a shareholding of 67,042 shares, representing 0.06% of the issued share capital of the Company.
In addition, the Company also received a notification from Mr Richard Jones, Chief Financial Officer of Medica, that on 4 November 2020 he purchased a total of 18,260 Shares at a price of 109.5p per Share.
Following this transaction, Richard Jones holds 18,260 shares, representing 0.02% of the issued share capital of the Company.
The Notification of Dealing Form for Dr Stuart Quin and Mr Richard Jones can be found below.
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||||||
a)
| Name | Dr Stuart Quin | |||||||
2
| Reason for the notification
| ||||||||
a)
| Position/status
| Chief Executive Officer
| |||||||
b)
| Initial notification /Amendment
| Initial notification in each case | |||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||||||
a)
| Name
| Medica Group PLC | |||||||
b)
| LEI
| 213800B8XE5FUSZF5Z16 | |||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.2p
GB00BYV24996 | |||||||
b)
| Nature of the transaction
| Market purchase | |||||||
c)
| Price(s) and volume(s) |
|
| ||||||
d)
| Aggregated information - Aggrated volume - Price
|
27,680 107.3 | |||||||
e)
| Date of the transaction
| 4 November 2020 | |||||||
f)
| Place of the transaction
| XLON | |||||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||||||
a)
| Name | Mr Richard Jones | |||||||
2
| Reason for the notification
| ||||||||
a)
| Position/status
| Chief Financial Officer | |||||||
b)
| Initial notification /Amendment
| Initial notification in each case | |||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||||||
a)
| Name
| Medica Group PLC | |||||||
b)
| LEI
| 213800B8XE5FUSZF5Z16 | |||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.2p
GB00BYV24996 | |||||||
b)
| Nature of the transaction
| Market purchase | |||||||
c)
| Price(s) and volume(s) |
| |||||||
d)
| Aggregated information - Aggrated volume - Price
|
18,260 109.5 | |||||||
e)
| Date of the transaction
| 4 November 2020 | |||||||
f)
| Place of the transaction
| XLON | |||||||